Dennis B. Gillings

Founder chez GHO Capital Partners LLP

Profil

Dennis B.
Gillings founded Quintiles Transnational Holdings, Inc. in 1982, where he worked as Class I Director from 2015 to 2016, IQVIA RDS, Inc. in 1982, where he worked as Lead Director from 2015 to 2018, The Life Sciences Foundation in 2010, where he worked as Director, and GHO Capital Partners LLP in 2014, where he is working as Non-Executive Chair from 2014.
Dr. Gillings also currently works at PharmaBio Development, Inc., as Chief Executive Officer from 2016, Neusentis, Inc., as Director from 1997, and Southampton University Development Trust, as Trustee.
Dr. Gillings also formerly worked at Association of Clinical Research Organizations, as Founding Chairman, Triangle Pharmaceuticals, Inc., as Director, Icagen, Inc., as Director from 1997 to 2011, UNC Health Care System, as Director, United Way of Greater Los Angeles, as Director, North Carolina Institute of Medicine, as Director, The University of Southampton, as Pro-Chancellor from 2006 to 2011, National Cancer Institute, as Consultant, and The University of North Carolina at Charlotte, as Professor.
Dr. Gillings received his doctorate degree in 1972 from The University of Exeter.

Postes actifs de Dennis B. Gillings

Sociétés	Poste	Début
Neusentis, Inc.	Director/Board Member	19/04/2011
Southampton University Development Trust	Director/Board Member	-
GHO Capital Partners LLP	Founder	01/01/2014
PharmaBio Development, Inc.	Chief Executive Officer	01/01/2016

Anciens postes connus de Dennis B. Gillings

Sociétés	Poste	Fin
IQVIA RDS, Inc.	Founder	12/04/2018
Quintiles Transnational Holdings, Inc.	Chief Executive Officer	01/10/2016
Icagen, Inc.	Director/Board Member	01/07/2011
The University of Southampton	Corporate Officer/Principal	01/01/2011
The Life Sciences Foundation	Founder	-

Formation de Dennis B. Gillings

The University of Exeter

Doctorate Degree